NVST
Price
$20.35
Change
+$0.36 (+1.80%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
3.32B
33 days until earnings call
STXS
Price
$2.92
Change
-$0.00 (-0.00%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
265.92M
41 days until earnings call
Interact to see
Advertisement

NVST vs STXS

Header iconNVST vs STXS Comparison
Open Charts NVST vs STXSBanner chart's image
Envista Holdings
Price$20.35
Change+$0.36 (+1.80%)
Volume$23.13K
Capitalization3.32B
Stereotaxis
Price$2.92
Change-$0.00 (-0.00%)
Volume$744
Capitalization265.92M
NVST vs STXS Comparison Chart in %
Loading...
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVST vs. STXS commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVST is a Buy and STXS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (NVST: $20.35 vs. STXS: $2.92)
Brand notoriety: NVST and STXS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: NVST: 35% vs. STXS: 13%
Market capitalization -- NVST: $3.32B vs. STXS: $265.92M
NVST [@Pharmaceuticals: Other] is valued at $3.32B. STXS’s [@Pharmaceuticals: Other] market capitalization is $265.92M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $157.06B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVST’s FA Score shows that 0 FA rating(s) are green whileSTXS’s FA Score has 0 green FA rating(s).

  • NVST’s FA Score: 0 green, 5 red.
  • STXS’s FA Score: 0 green, 5 red.
According to our system of comparison, both NVST and STXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVST’s TA Score shows that 4 TA indicator(s) are bullish while STXS’s TA Score has 3 bullish TA indicator(s).

  • NVST’s TA Score: 4 bullish, 4 bearish.
  • STXS’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both NVST and STXS are a good buy in the short-term.

Price Growth

NVST (@Pharmaceuticals: Other) experienced а -2.77% price change this week, while STXS (@Pharmaceuticals: Other) price change was +4.09% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.23%. For the same industry, the average monthly price growth was -3.27%, and the average quarterly price growth was +8.57%.

Reported Earning Dates

NVST is expected to report earnings on Oct 29, 2025.

STXS is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.23% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVST($3.32B) has a higher market cap than STXS($266M). STXS YTD gains are higher at: 28.289 vs. NVST (5.495). NVST has higher annual earnings (EBITDA): 303M vs. STXS (-22.41M). NVST has more cash in the bank: 1.11B vs. STXS (6.97M). STXS has less debt than NVST: STXS (5.73M) vs NVST (1.6B). NVST has higher revenues than STXS: NVST (2.55B) vs STXS (31.8M).
NVSTSTXSNVST / STXS
Capitalization3.32B266M1,249%
EBITDA303M-22.41M-1,352%
Gain YTD5.49528.28919%
P/E Ratio62.47N/A-
Revenue2.55B31.8M8,028%
Total Cash1.11B6.97M15,947%
Total Debt1.6B5.73M27,868%
FUNDAMENTALS RATINGS
NVST vs STXS: Fundamental Ratings
NVST
STXS
OUTLOOK RATING
1..100
6281
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
91100
PRICE GROWTH RATING
1..100
5240
P/E GROWTH RATING
1..100
5054
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVST's Valuation (73) in the null industry is in the same range as STXS (100) in the Medical Specialties industry. This means that NVST’s stock grew similarly to STXS’s over the last 12 months.

NVST's Profit vs Risk Rating (100) in the null industry is in the same range as STXS (100) in the Medical Specialties industry. This means that NVST’s stock grew similarly to STXS’s over the last 12 months.

NVST's SMR Rating (91) in the null industry is in the same range as STXS (100) in the Medical Specialties industry. This means that NVST’s stock grew similarly to STXS’s over the last 12 months.

STXS's Price Growth Rating (40) in the Medical Specialties industry is in the same range as NVST (52) in the null industry. This means that STXS’s stock grew similarly to NVST’s over the last 12 months.

NVST's P/E Growth Rating (50) in the null industry is in the same range as STXS (54) in the Medical Specialties industry. This means that NVST’s stock grew similarly to STXS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVSTSTXS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 22 days ago
66%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 10 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
63%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCBLX36.57N/A
N/A
Green Century Balanced
VCBCX21.07N/A
N/A
VALIC Company I Systematic Growth
OIEIX25.76N/A
N/A
JPMorgan Equity Income A
PLVJX19.89N/A
N/A
Principal Large Cap Value III J
SBASX12.79N/A
N/A
Segall Bryant &Hamill Small Cap Cre Ins

NVST and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVST has been loosely correlated with A. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if NVST jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVST
1D Price
Change %
NVST100%
+1.80%
A - NVST
57%
Loosely correlated
+1.22%
MTD - NVST
56%
Loosely correlated
-0.56%
SOLV - NVST
55%
Loosely correlated
+1.29%
XRAY - NVST
55%
Loosely correlated
+1.05%
BIO - NVST
53%
Loosely correlated
+0.33%
More

STXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, STXS has been loosely correlated with TWST. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if STXS jumps, then TWST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STXS
1D Price
Change %
STXS100%
+0.17%
TWST - STXS
37%
Loosely correlated
+0.64%
PSNL - STXS
33%
Loosely correlated
+0.92%
NVST - STXS
33%
Loosely correlated
+1.80%
VCYT - STXS
33%
Poorly correlated
+1.89%
RGEN - STXS
33%
Poorly correlated
+3.25%
More